BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/12/2026 11:20:20 AM | Browse: 77 | Download: 243
 |
Received |
|
2025-09-10 08:35 |
|
Peer-Review Started |
|
2025-09-10 08:36 |
|
First Decision by Editorial Office Director |
|
2025-10-13 08:51 |
|
Return for Revision |
|
2025-10-13 08:51 |
|
Revised |
|
2025-10-21 06:13 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-16 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-16 09:33 |
|
Articles in Press |
|
2025-12-16 09:33 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-04 00:38 |
|
Publish the Manuscript Online |
|
2026-02-12 11:20 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Should the theory of methotrexate-induced liver toxicity be abandoned?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yahya Al-Hammada, Sinan Sharba and Samer Al-Dury |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Samer Al-Dury, MD, PhD, School of Public Health and Community Medicine, University of Gothenburg, Universitetsplatsen 1, Gothenburg 40530, Sweden. samer.al-dury@gu.se |
| Key Words |
Risk stratification; Noninvasive monitoring; Metabolic risk factors; Hepatotoxicity; Liver fibrosis; Methotrexate |
| Core Tip |
Methotrexate (MTX) has long been associated with a presumed risk of hepatotoxicity and progressive liver fibrosis, largely based on early biopsy-era studies. Contemporary evidence using non-invasive fibrosis assessment shows that significant fibrosis is uncommon in MTX-treated patients and more strongly linked to metabolic dysfunction-associated steatotic liver disease and related risk factors such as obesity, diabetes, and insulin resistance. This minireview challenges the traditional perception of intrinsic MTX hepatotoxicity and argues for risk-based rather than drug-based monitoring strategies. |
| Publish Date |
2026-02-12 11:20 |
| Citation |
Al-Hammada Y, Sharba S, Al-Dury S. Should the theory of methotrexate-induced liver toxicity be abandoned? World J Hepatol 2026; 18(2): 113743 |
| URL |
https://www.wjgnet.com/1948-5182/full/v18/i2/113743.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v18.i2.113743 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
